Document Detail

Improvement in wound healing by epidermal growth factor (EGF) ointment. II. Effect of protease inhibitor, nafamostat, on stabilization and efficacy of EGF in burn.
MedLine Citation:
PMID:  1861238     Owner:  NLM     Status:  MEDLINE    
The healing effect of human epidermal growth factor (hEGF) on second degree burn was studied in rats. No improvement in wound healing was found on topical application of EGF alone to burn sites, but an ointment containing EGF and nafamostat mesilate (NM), a protease inhibitor, accelerated the healing rate of burns. The dry weight of the granulation tissue on the wound site in the group treated with EGF plus NM ointment did not change, although that in other groups decreased. After treatment with EGF ointment containing NM, the content of uronic acid, as an index of acid mucopolysaccharide, at 3 d after burn rapidly increased and had recovered to nearly normal levels at 7 d after burn. However, the uronic acid content in the other groups (control, EGF alone, and NM alone) showed a higher value at 7 d than at 3 d. When compared with the control values significant increases in hydroxyproline, as an index of collagen, in the wound site were observed at 7 d after treatment with EGF ointment containing NM. The degradation of [125I]EGF in burned tissue homogenate decreased significantly in a concentration-dependent manner in the presence of NM. Body weights did not change after treatment with EGF plus NM ointment, although the body weights of other treatment groups decreased after burn, suggesting that EGF ointment containing the protease inhibitor, NM, alleviated the effects of burn shock. These findings indicate that the stabilization of EGF at the wound site is an important factor for the expression of its healing effects.
Y Kiyohara; F Komada; S Iwakawa; M Hirai; T Fuwa; K Okumura
Related Documents :
8960238 - Tensides from the group of propylene oxide and ethylene oxide copolymers. part xi. solu...
23987328 - Sulfonated hierarchical h-usy zeolite for efficient hydrolysis of hemicellulose/cellulose.
1098688 - 5-fluorouracil in the treatment of common warts of the hands. a double-blind study.
8099958 - In-vitro permeability to salicylic acid of human, rodent, and shed snake skin.
16143818 - Factors influencing the synonymous codon and amino acid usage bias in at-rich pseudomon...
17959378 - Chemically modified maize cobs waste with enhanced adsorption properties upon methyl or...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of pharmacobio-dynamics     Volume:  14     ISSN:  0386-846X     ISO Abbreviation:  J. Pharmacobio-dyn.     Publication Date:  1991 Jan 
Date Detail:
Created Date:  1991-09-04     Completed Date:  1991-09-04     Revised Date:  2003-11-14    
Medline Journal Info:
Nlm Unique ID:  7901854     Medline TA:  J Pharmacobiodyn     Country:  JAPAN    
Other Details:
Languages:  eng     Pagination:  47-52     Citation Subset:  IM    
Department of Hospital Pharmacy, School of Medicine, Kobe University, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Burns / drug therapy*
Drug Interactions
Drug Stability
Drug Therapy, Combination
Epidermal Growth Factor / therapeutic use*
Guanidines / therapeutic use*
Hydroxyproline / analysis
Rats, Inbred Strains
Serine Proteinase Inhibitors / therapeutic use*
Uronic Acids / analysis
Wound Healing / drug effects
Reg. No./Substance:
0/Guanidines; 0/Ointments; 0/Serine Proteinase Inhibitors; 0/Uronic Acids; 51-35-4/Hydroxyproline; 62229-50-9/Epidermal Growth Factor; 81525-10-2/nafamostat

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Antioxidative effect of protoporphyrin on lipid peroxidation in tissue homogenates of intravenously ...
Next Document:  Stimulatory effect of guanine nucleotides on prostaglandin E1 binding to murine renal outer medulla.